Sino Medical Sciences Stock Shares Owned By Insiders

688108 Stock   10.58  0.30  2.76%   
Sino Medical Sciences fundamentals help investors to digest information that contributes to Sino Medical's financial success or failures. It also enables traders to predict the movement of Sino Stock. The fundamental analysis module provides a way to measure Sino Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sino Medical stock.
Other Current LiabTotal Assets7.5M6.3M8.7M12.0M35.5M137.0K123.3K117.1K806.1M1.2B1.2B1.1B1.1B1.2B1.4B1.0B100%
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sino Medical Sciences Company Shares Owned By Insiders Analysis

Sino Medical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Sino Medical Shares Owned By Insiders

    
  33.74 %  
Most of Sino Medical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sino Medical Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 33.74% of Sino Medical Sciences are shares owned by insiders. This is 122.27% higher than that of the Health Care Equipment & Supplies sector and 116.98% higher than that of the Health Care industry. The shares owned by insiders for all China stocks is notably lower than that of the firm.

Sino Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sino Medical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sino Medical could also be used in its relative valuation, which is a method of valuing Sino Medical by comparing valuation metrics of similar companies.
Sino Medical is currently under evaluation in shares owned by insiders category among its peers.

Sino Fundamentals

Return On Equity-0.0047
Return On Asset-0.0247
Profit Margin(0.01) %
Operating Margin0.03 %
Current Valuation4.41 B
Shares Outstanding413.46 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315%10%15%20%25%30%
Shares Owned By Insiders33.74 %
Shares Owned By Institutions9.61 %
Price To Book5.25 X
Price To Sales10.46 X
Revenue343.26 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20%0%20%40%60%
Gross Profit249.36 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40%-20%0%20%40%60%
EBITDA711.57 K
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-250%-200%-150%-100%-50%0%
Net Income(39.63 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-600%-400%-200%0%200%
Total Debt69.27 M
Book Value Per Share2.07 X
Cash Flow From Operations56.84 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-300%-200%-100%0%100%200%
Earnings Per Share(0.02) X
Target Price14.0
Number Of Employees652
Beta0.54
Market Capitalization4.5 B
Total Asset1.19 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%350%
Retained Earnings(234.73 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-300%-200%-100%0%100%200%300%
Working Capital192.9 M
Net Asset1.19 B

About Sino Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sino Medical Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sino Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sino Medical Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Sino Stock

Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.


 
News Freq…Investor S…